Peaccel and SeSaM-Biotech today jointly announced the signature of a collaboration agreement. Under the agreement, PEACCEL and SeSaM-Biotech will develop improved enzyme variants of a commercially important enzyme family…
Peaccel and SeSaM-Biotech today jointly announced the signature of a collaboration agreement. Under the agreement, PEACCEL and SeSaM-Biotech will develop improved enzyme variants of a commercially important enzyme family…
PEACCEL’s latest paper is available on https://doi.org/10.1371/journal.pone.0186215
Meet Matthieu NG FUK CHONG and Rudy PANDJAITAN to discover our poster entitled “Disruptive mixed in vitro-in silico approach for protein engineering and screening: Case study of the engineering of the enantioselectivity of an epoxide hydrolase“.
PEACCEL is a Sponsor.
PEACCEL will give a presentation “Disruptive mixed in vitro-in silico approach for protein engineering and screening” on May 10 between 12:25-12:45.
Meet Matthieu NG FUK CHONG to discover our poster entitled “Automatic reconstruction and modelling of biocatalyst systems for the production of specific biochemical compounds“.
Meet Rudy Pandjaitan and Matthieu NG FUK CHONG at the PEACCEL booth on February 2-3 2017.
Peaccel will give a presentation “Disruptive mixed in vitro-in silico approach for protein engineering and screening on December 1 between 14:30-15:15
PEACCEL is a PRESENTING COMPANY in the «Technologies and Tools: Protein Engineering & Screening» track: November 8, at 11:30, Room: Rheinsaal 2 on level 2.
Come to listen Matthieu NG FUK CHONG during his talk “Disruptive mixed in vitro-in silico approach for enzyme/protein engineering and screening” on November 16 between 12:15 – 13:30.
PEACCEL announces its certification by the U.S. federal government’s System for Award Management (SAM), which makes it eligible for contracts, assistance awards, and to do business with the federal government.
PEACCEL is a Sponsor.
Meet Matthieu NG FUK CHONG to discover our poster entitled “Disruptive mixed in vitro-in silico approach for enzyme/protein engineering and screening”.
